CoChat

Effects of Open-Label Atomoxetine on African-American and Caucasian Pediatric Outpatients with Attention-Deficit/Hyperactivity Disorder

Durell, Todd M., Pumariega, Andres J., Rothe, Eugenio M., Tamayo, Jorge M., Baron, David, Williams, David · 2009 · Annals of Clinical Psychiatry
Cited by 19

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Background: Data on the management of attention-deficit/hyperactivity disorder (ADHD) in African-American children and adolescents are limited. Methods: This study sought to evaluate the tolerability, safety, and efficacy of atomoxetine hydrochloride in the management of ADHD in African-American children and adolescents by conducting a post hoc subgroup analysis of 2 multicenter, open-label studies. Results: Atomoxetine was safe and well tolerated, with ≥3.0% of African-Americans and Caucasians discontinuing treatment because of adverse events. A significantly higher proportion of Caucasians reported ≥1 treatment-emergent adverse event, including vomiting (7.2% vs 1.2%; P = .037) and fatigue (6.1% vs 0%; P = .012). No serious safety concerns were observed. Changes from baseline in height, weight, and hemodynamic variables were modest and similar in both racial subgroups. African-Americans and Caucasians showed significant improvement from baseline to end point in the mean ADHD Rating Scale-IV-Parent Version: Investigator Administered and Scored (ADHDRS-IV-P:I). Scores decreased by 20.1 in African-Americans and by 19.55 in Caucasians, without significant between-group differences. Patients in both racial groups experienced similar, significant improvements in ADHDRS-IV-P:I inattention and hyperactivity-impulsivity symptoms, Clinical Global Impression-ADHD-Severity, and Conners’ Parent Rating Scale-Revised: Short Form. Conclusions: Atomoxetine exhibited similar tolerability, safety, and efficacy profiles in African-Americans and Caucasians with ADHD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/104012370902100104

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 19

Metadata

Authors
Durell, T. M., Pumariega, A. J., Rothe, E. M., Tamayo, J. M., Baron, D., & Williams, D.
Venue
Annals of Clinical Psychiatry
Published
2009-02
Volume
21
Issue
1
Pages
26-37
ISSN
  • 1040-1237 (ISSN-L)
  • 1547-3325
OpenAlex
W94022314
Cited by
19
References
10
FWCI
1.29
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Open-Label Atomoxetine on African-American and Caucasian Pediatric Outpatients with Attention-Deficit/Hyperactivity Disorder. https://app.cochat.ai/papers/10.1177/104012370902100104
The paper
Durell, T. M., Pumariega, A. J., Rothe, E. M., Tamayo, J. M., Baron, D., & Williams, D. (2009). Effects of Open-Label Atomoxetine on African-American and Caucasian Pediatric Outpatients with Attention-Deficit/Hyperactivity Disorder. Annals of Clinical Psychiatry. https://doi.org/10.1177/104012370902100104

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.